PREVENTIONGENETICS INC.

In News

EXACT SCIENCES CORP SEC 10-K Report - TradingView

TradingView - Feb 13, 2026

PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis - Business Wire

Business Wire - Mar 13, 2025

What to know about Exact Sciences. The Madison company was sold to Abbottfor $23 billion. - Milwaukee Journal Sentinel

Milwaukee Journal Sentinel - Nov 20, 2025

Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients - PR Newswire

PR Newswire - Jan 09, 2022

Rare Disease Genetic Testing Market Size | CAGR Of 13.1% - Market.us

Market.us - Apr 18, 2023

Feds' Biotech Enforcement Efforts Are Too Heavy-Handed - Law360

Law360 - May 13, 2024

Rare Disease Genetic Testing Market Size Report 2026-2033 - Grand View Research

Grand View Research - Jun 01, 2020

Exact Sciences pauses work on new R&D center in Madison - The Business Journals

The Business Journals - Feb 06, 2023

Leadership Marshfield Council announces 2019-20 selections - Hub City Times

Hub City Times - Sep 06, 2019

Exact Sciences (EXAS) Stock Price, News & Analysis - Stock Titan

Stock Titan - Apr 24, 2025

MACCI announces Leadership Marshfield graduates - Marshfield News-Herald

Marshfield News-Herald - Apr 19, 2016

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment